AI Verdict
LINK has stronger fundamentals based on our AI analysis.
LIPO vs LINK Fundamental Comparison
| Metric | LIPO | LINK |
|---|---|---|
| Revenue | $216,117.0 | $11.9M |
| Net Income | $-3.9M | $-1.6M |
| Net Margin | -1,799.1% | -13.6% |
| ROE | -261.4% | -17.5% |
| ROA | -165.5% | -13.8% |
| Current Ratio | 3.24x | 3.79x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-1.07 | $-0.13 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LIPO vs LINK: Frequently Asked Questions
Is LIPO or LINK a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LINK has stronger fundamentals. LIPO is rated STRONG SELL (90% confidence) while LINK is rated SELL (68% confidence). This is not investment advice.
How does LIPO compare to LINK fundamentally?
LIPELLA PHARMACEUTICALS INC. has ROE of -261.4% vs INTERLINK ELECTRONICS INC's -17.5%. Net margins are -1,799.1% vs -13.6% respectively.
Which stock pays higher dividends, LIPO or LINK?
LIPO has a dividend yield of N/A or no dividend while LINK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LIPO or LINK for long term?
For long-term investing, consider that LIPO has STRONG SELL rating with 90% confidence, while LINK has SELL rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LIPO vs LINK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LIPO vs LINK, the AI consensus favors LINK based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.